Trajan joins BioMelbourne Network

Trajan joins BioMelbourne Network

January 31, 2014

Trajan Scientific and Medical (Trajan) is now a member of BioMelbourne Network. As a group of companies with headquarters in Melbourne, Trajan is looking forward to strengthening connections with local scientific organisations, business leaders and government.

Stephen Tomisich, Trajan’s Chief Executive Officer said, “We hope our membership helps us to engage with other members to support and contribute to the success of the Australian scientific industry, in particular biotechnology in Victoria.

“We are proud to be an Australian owned and operated global company, building on humble beginnings in Ringwood with SGE Analytical Science over 50 years ago, growing to develop new analytical technologies for the scientific community and society.”

Trajan’s focus is on developing and commercializing technologies that enable analytical systems to be more selective, sensitive and specific for biological, environmental or food related measurements, especially those that can lead to portability, miniaturization and affordability.

“We seek opportunities for each of our companies with their unique capabilities. Trajan is able to facilitate collaboration with one or more of our companies in Australia and around the world.” said Robert Lyon, Head of Corporate Development at Trajan.

Trajan encompasses a group of companies including SGE Analytical Science, Grale HDS and SciMed Precision with over 300 staff worldwide, and customers in over 100 countries.

SGE Analytical Science is a world leader in creating components and consumables used in scientific analysis. SGE has substantial capability in materials science, chemistry, fabrication and distribution.

SciMed Precision offers complete solutions in design and production engineering of high precision complex components for analytical and life science applications.

Grale HDS is a pathology supply partner like no other. Supplying quality products for more than 30 years, they assist laboratory managers tackle operational challenges.

“Through true customer focus and partnerships, we aim to make a positive impact on the world of analytical and medical science.” said Mr Tomisich. 

More Information
BioMelbourne Network www.biomelbourne.org




Also in News

Trajan Scientific and Medical continues its focus on Microsampling
Trajan Scientific and Medical continues its focus on Microsampling

April 20, 2022

Trajan Scientific and Medical, (Trajan, ASX:TRJ) partnered with researchers at The University of Queensland to develop a skin microbiopsy device which takes tissue samples smaller than 0.5mm in diameter.  It can be used to collect biopsies for skin conditions, including skin cancers.

Read More

Cathy Cordova Appointed Trajan's General Manager of Microsampling Unit
Cathy Cordova Appointed Trajan's General Manager of Microsampling Unit

February 16, 2022

Cathy Cordova has been appointed the General Manager of the consolidated Microsampling Business Unit for Trajan Scientific and Medical.

Read More

Dr Xumei Gao (Bryan) awarded REDI fellowship to partner with Trajan.
Dr Xumei Gao (Bryan) awarded REDI fellowship to partner with Trajan.

January 27, 2022

 Dr Xumei Gao (Bryan) a Postdoctoral Researcher from the ARC Training Centre for Personalized Therapeutics Technologies at the University of Melbourne, has been awarded a REDI fellowship to partner with Trajan.

Read More